2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

Mach, FrançoisFrançoisMachBaigent, ColinColinBaigentCatapano, Alberico LAlberico LCatapanoKoskinas, KonstantinosKonstantinosKoskinasCasula, ManuelaManuelaCasulaBadimon, LinaLinaBadimonChapman, M JohnM JohnChapmanDe Backer, Guy GGuy GDe BackerDelgado, VictoriaVictoriaDelgadoFerence, Brian ABrian AFerenceGraham, Ian MIan MGrahamHalliday, AlisonAlisonHallidayLandmesser, UlfUlfLandmesserMihaylova, BorislavaBorislavaMihaylovaPedersen, Terje RTerje RPedersenRiccardi, GabrieleGabrieleRiccardiRichter, Dimitrios JDimitrios JRichterSabatine, Marc SMarc SSabatineTaskinen, Marja-RiittaMarja-RiittaTaskinenTokgozoglu, LaleLaleTokgozogluWiklund, OlovOlovWiklund2024-09-022024-09-022020-01-01https://boris-portal.unibe.ch/handle/20.500.12422/37454enGuidelines apolipoprotein B cholesterol dyslipidaemias familial hypercholesterolaemia high-density lipoproteins lipoprotein remnants lipoprotein(a) low-density lipoproteins total cardiovascular risk treatment (adherence) treatment (drugs) treatment (lifestyle) triglycerides very low-density lipoproteins600 - Technology::610 - Medicine & health2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.article10.7892/boris.1472063150441810.1093/eurheartj/ehz455